Search Results
Sep 03, 2026, 09:00 ET ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates
More news about: Carl Zeiss Meditec AG
Sep 03, 2026, 09:00 ET ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates
More news about: Carl Zeiss Meditec AG
Sep 03, 2026, 09:00 ET McDermott Will & Schulte adds cross-border capital markets partner Sina Hekmat in New York
capital is hard to ignore, and the chance to plug a genuinely multijurisdictional practice into it was compelling," Sina said. "Clients are looking beyond any single market, and I'm looking forward to pairing my European and US work with the firm's strength across capital markets, structured finance, and M&A."With
More news about: McDermott Will & Schulte
Sep 03, 2026, 09:00 ET Liquid Fuels Logistics Leader Murex Selects Seekr to Accelerate AI-Powered Operations with a Flexible, Model-Agnostic Approach
domain-specific large language models (LLMs), vision language models (VLMs) that understand the physical world, and AI agents trained on their own data – across any infrastructure, including sovereign deployments. Backed by robust verification and validation tools that surface the provenance and intent behind every
More news about: Seekr Technologies
Sep 03, 2026, 09:00 ET Hollyland Launches Pyro 7 Ultra, an All-in-One Wireless Monitoring System for Professional Film Production
without interoperability concerns or production delays. The result is a reliable, flexible, and scalable system that adapts easily to productions of any size.Pricing and AvailabilityThe Hollyland Pyro 7 Ultra is available now through authorized Hollyland distributors, Amazon, and
More news about: Hollyland
Sep 03, 2026, 09:00 ET Hollyland Launches Pyro 7 Ultra, an All-in-One Wireless Monitoring System for Professional Film Production
without interoperability concerns or production delays. The result is a reliable, flexible, and scalable system that adapts easily to productions of any size.Pricing and AvailabilityThe Hollyland Pyro 7 Ultra is available now through authorized Hollyland distributors, Amazon, and
More news about: Hollyland
Sep 03, 2026, 09:00 ET HIMS Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Hims & Hers Health, Inc.
court-appointed investor who represents the interests of all class members throughout the litigation. Serving as lead plaintiff is not required to share in any potential recovery. Investors who do not seek appointment may remain absent class members if the case proceeds and later resolves successfully.Shareholders
More news about: Robbins LLP
Sep 03, 2026, 09:00 ET Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
with the Securities and Exchange Commission on March 31, 2026, and in its other filings with the SEC. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as required by applicable law.
More news about: Co-Diagnostics
Sep 03, 2026, 08:56 ET Blue Moon Acquires Strategic Water Rights and Land Package for Springer
Company cannot guarantee that any forward-looking information will materialize and readers are cautioned not to place undue reliance on this forward-looking information. Except as required by applicable securities laws, the Company is under no obligation to update or revise any forward-looking information,
More news about: Blue Moon Metals
Sep 03, 2026, 08:55 ET AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
encouraged not to use this publication as the basis for any investment decision.MEL and its owner/operators do not own any shares of MindWalk Holdings Corp., but reserve the right to buy and sell shares of MindWalk Holdings Corp. at any time without any further notice commencing immediately and ongoing,
More news about: Equity Insider
Sep 03, 2026, 08:51 ET EClinCloud Surpasses 1,100 Clinical Trials Across 10+ Countries as Its Unified AI-Driven Platform Expands Worldwide
international standards from day one. When data, operations and endpoint assessment share one backbone, teams see issues earlier and decide with confidence — in any market."The company's customer base — 54% pharmaceutical companies, 23% biotechs and 17% contract research organizations, with device manufacturers
More news about: EClinCloud
Sep 03, 2026, 08:50 ET Matricelf Receives FDA Feedback Supporting Key Elements of Proposed First in Human Clinical Trial for NewRal Spinal Cord Injury Program
patient's own tissue to create an autologous engineered neural tissue transplant.NewRal remains investigational, has not been approved by the FDA or any other regulatory authority, and has not yet been evaluated in humans.About MatricelfMatricelf Ltd. is a regenerative medicine company
More news about: Matricelf Ltd.
Sep 03, 2026, 08:38 ET Authenticx Expands Pharmacovigilance AI to Automate Downstream Safety Workflows With Accuracy
and inconsistency to regulated workflows. Federal regulations require applicants to promptly review adverse drug experience information received from any source, with serious and unexpected adverse drug experiences generally reportable within 15 calendar days of receipt. Authenticx introduced its
More news about: Authenticx
Sep 03, 2026, 08:34 ET AbbVie Completes Acquisition of Apogee Therapeutics
acquired IPR&D and milestones expense incurred year-to-date through the second quarter. The company's 2026 adjusted diluted EPS guidance excludes any impact from acquired IPR&D and milestones that may be incurred beyond the second quarter of 2026, as both cannot be reliably forecasted.AbbVie
More news about: AbbVie
Sep 03, 2026, 08:31 ET LightPath Technologies to Host Fourth Quarter Fiscal 2026 Earnings Call on September 10 at 5:00 p.m. Eastern Time
required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
More news about: LightPath Technologies
Sep 03, 2026, 08:31 ET Medical Device Registration Verification 2026: Analysis of 15 National Public Data Files Finds Row Counts Mislead Compliance and Market-Sizing Decisions, Driven by Divergent File Structures and Completeness Gaps: Pure Global
EUDAMED and additional jurisdictions including Australia, Canada, Korea, Japan and Colombia. Data snapshots range from May through August 2026. Before any two files can be compared, the study argues, the grain of each must be named: a product listing, a procedure bulletin, an issuance list or a catalog
More news about: Pure Global
Sep 03, 2026, 08:30 ET Utilities Are Short Billions of Pounds of Uranium They Haven't Bought Yet, and the Math Is Getting Harder Every Year
will not reach production. This commentary describes a sector and the companies active within it, and is not a prediction about any company's stock or a recommendation of any kind. But with utilities under-contracted, supply constrained, and policy squarely behind domestic nuclear fuel, the sector is
More news about: USA News Group
Sep 03, 2026, 08:30 ET Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $380 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
release, and Eightco undertakes no duty to update this information or to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect actual results or any change in its expectations.
More news about: Eightco Holdings (NASDAQ: ORBS)
Sep 03, 2026, 08:30 ET Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $380 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
release, and Eightco undertakes no duty to update this information or to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect actual results or any change in its expectations.
More news about: Eightco Holdings (NASDAQ: ORBS)
Sep 03, 2026, 08:30 ET Leifras Awarded Contract by Nagoya City to Launch Club Activities for Students with Disabilities
allowing one-time participation and participation accompanied by a parent or guardian: No disability certificate or similar documentation is required. Any student who requires accommodations during activities may participate free of charge. Each session is designed to last approximately 90 minutes. Students
More news about: LEIFRAS Co., Ltd.
Sep 03, 2026, 08:30 ET Echo's Mythos Readiness Report Finds AI Has Solved Vulnerability Discovery, Making Judgment the Scarce Resource
findings Mythos originally rated "Critical" held up under independent review, and fewer than 10% of the model's 23,019 candidate findings have undergone any external validation at all."AI hasn't just made it faster to find a vulnerability; it's made it faster to be wrong about one," said Eylam Milner,
More news about: Echo Software Inc.
Sep 03, 2026, 08:30 ET Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale
on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence
More news about: Genedata
Sep 03, 2026, 08:30 ET FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website, www.sec.gov. These risks, uncertainties,
More news about: FibroBiologics, Inc.
Sep 03, 2026, 08:15 ET New Survey Finds Colleges Inheriting Students With Greater Mental Health Needs
educational institutions ranked highest, though none were trusted by a majority of either student cohort. One in 4 of all students surveyed don't trust any of the institutions tested. Financial pressure weighs heavily on students. Nearly four in ten college seniors (39%) report working more
More news about: Uwill, Inc
Sep 03, 2026, 08:07 ET J.S. Held Lending Climate Survey Finds Growing Lender Caution Amid Rising Economic and Geopolitical Risks
Fortune 100 Companies.J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held is not a law firm and does not provide legal advice. Securities offered through PM Securities, LLC, d/b/a
More news about: J.S. Held